Clinical trial
Efficacy and Safety of Fecal Microbiota Transplantation for Epilepsy
NCT02889627 is registered in ClinicalTrials.gov with The Second Hospital of Nanjing Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Fecal Microbiota Transplantation for Epilepsy
- Lead sponsor
- The Second Hospital of Nanjing Medical University
- Phase
- Phase 2/3
- Overall status
- Unknown status
- Start date
- November 30, 2016
- Completion date
- December 31, 2025
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.